Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szazhalombatta – page 92

1 121 clinical trials in Szazhalombatta, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szazhalombatta at a glance
1 121
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 121 trials in Szazhalombatta

Open in trial search

Cardiovascular disorder+1

Not recruiting

Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:LY3437943 sodium
  • Sponsor:Eli Lilly & Co.

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Bronchiectasis

Not recruiting

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Effects and Safety of Upadacitinib for Children with Polyarticular Juvenile Idiopathic Arthritis

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Status epilepticus

Not recruiting

Study on Ganaxolone for Patients with Refractory Status Epilepticus

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Diabetic retinopathy

Not recruiting

Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 764524
  • Sponsor:Boehringer Ingelheim International GmbH

Neoplasm

Not recruiting

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Olaparib
  • Sponsor:Astrazeneca AB

Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Avacincaptad Pegol
  • Sponsor:Astellas Pharma Global Development Inc.

Colitis ulcerative

Not recruiting

Study on VE202 for Patients with Mild-to-Moderate Ulcerative Colitis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Ramosum, Live
  • Sponsor:Vedanta Biosciences Inc.

Dermatitis atopic

Not recruiting

Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Szazhalombatta

What the registry says about research in the country

01 Respiratory Disease Management

Innovative clinical research focusing on moderate-to-severe asthma, evaluating new therapeutic approaches including dupilumab and amlitelimab for improved lung function and symptom control.

  • Long-term lung function preservation
  • Novel therapeutic evaluation
  • Disease control optimization

Multiple trials are exploring preventive strategies and treatment effectiveness in asthma management.

02 COPD Treatment Innovation

Comprehensive studies examining chronic obstructive pulmonary disease treatments, including evaluation of triple therapy combinations and novel biological agents.

  • Exacerbation reduction strategies
  • Cardiopulmonary outcomes
  • Advanced therapeutic combinations

Research focuses on improving quality of life and reducing disease progression in COPD patients.

03 Advanced Respiratory Therapeutics

Investigation of innovative biological treatments for both asthma and COPD, including studies of benralizumab and itepekimab for patients with severe symptoms.

  • Long-term safety assessment
  • Targeted biological therapies
  • Patient response monitoring

These trials aim to establish new standards in respiratory disease treatment.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.